Name: 글로벌 시장 동향
SKU: MD4156
Availability: InStock

보고서 요약(국문)

개요
전 세계 혈액응고 모니터링 제품 시장은 2023년 YY백만 달러에 도달했으며, 2024년부터 2031년까지 연평균 성장률(CAGR) YY%로 성장하여 2031년에는 YY백만 달러에 이를 것으로 예상됩니다.
혈액응고 검사는 혈액의 응고 능력과 응고에 걸리는 시간을 평가합니다. 이 검사는 의사가 과다 출혈이나 혈관 내 혈전 형성(혈전증) 위험을 판단하는 데 도움을 줄 수 있습니다. 혈액응고 모니터링 장치는 혈액이 응고되는 데 걸리는 시간을 측정하는 의료 기기입니다. 이 정보는 다양한 출혈 및 응고 장애를 진단하고 관리하는 데 필수적입니다.
이러한 장치는 혈액 응고 과정의 여러 요소를 측정하여 의료진이 출혈 장애를 식별하고, 혈액 희석제(항응고제)의 효과를 모니터링하고, 혈액 응고 치료 옵션을 결정하는 데 도움을 줍니다.

시장 동향: 성장 동인 및 제약 요인
혈전 모니터링 제품 증가
향상된 혈전 모니터링 제품 및 기기의 증가가 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 병원과 환자의 요구를 충족하기 위한 새로운 첨단 제품 출시가 증가하고 있습니다.
예를 들어, 2024년 3월 호주 바이오센서 회사인 유니버설 바이오센서(Universal Biosensors)는 Xprecia Prime 혈전 분석기에 대해 미국 FDA 및 CLIA로부터 Class II 기기 승인 면제 허가를 받았습니다. Xprecia Prime은 휴대용 혈전 모니터링 기기로, 특히 와파린과 같은 비타민 K 길항제 경구 항응고 요법을 받는 환자에게 빠르고 정확한 PT/INR 검사를 제공합니다.
또한 유니버설 바이오센서는 2023년 11월에 새롭고 개선된 혈전 모니터링 기기인 Xprecia Prime 혈전 분석기를 출시했습니다. Xprecia Prime은 작고 휴대하기 쉬우며 정확하고 사용이 간편합니다.

또한 2023년 7월, ARKRAY USA, Inc.는 CoaguSense, Inc.와의 전략적 파트너십을 통해 Assure PT Care PT/INR 모니터링 시스템을 출시했습니다. 이처럼 시장에 출시되는 제품 수가 증가함에 따라 예측 기간 동안 시장 성장이 촉진될 것입니다.
검사 장비의 높은 비용
POC 응고 모니터링 장비와 같은 의료 기기의 사용을 제한하는 주요 이유는 모니터링을 위한 실험실 검사에 비해 이러한 장비의 비용이 높다는 점입니다. 경제적 여건이 제한적인 저소득 및 중소득 국가(LIC/MIC)는 이러한 측면에서 상당한 어려움에 직면해 있습니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
글로벌 응고 모니터링 제품 시장은 제품, 최종 사용자 및 지역별로 세분화됩니다.
점탄성 응고 모니터 부문이 시장 성장을 주도할 것으로 예상됩니다.
점탄성 혈액 분석은 전혈에서 혈전 형성 시작부터 섬유소 용해까지 전반적인 응고 과정을 동적으로 체외에서 평가합니다. 이 연구는 혈소판, 적혈구, 피브린, 응고 인자 및 트롬빈을 포함한 모든 응고 구성 요소의 상호 작용을 다룹니다. 점탄성 응고 모니터(VCM) 시스템은 처리되지 않은 전혈의 유리 표면 활성화를 활용하는 혁신적인 기술입니다.
이 시스템은 소형 휴대용 기기로, 환자 침상에서 응고-섬유소 용해 과정의 점탄성 검사를 수행할 수 있습니다. 추출된 혈액과 카트리지 내부의 유리 사이의 넓은 접촉면으로 인해 빠른 응고가 시작됩니다. 따라서 이러한 기기의 효율성은 예측 기간 동안 해당 시장 부문의 성장을 견인할 것으로 예상됩니다.
지역 분석
북미는 응고 모니터링 제품 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
북미는 다수의 제조업체, 최첨단 시설을 갖춘 병원, 그리고 이 지역의 혈액 질환 유병률 증가로 인한 제품 수요 증가로 인해 시장에서 주도적인 위치를 차지할 것으로 예상됩니다. 시장 주요 업체들이 시장 성장을 촉진할 수 있는 포트폴리오 확장을 위해 다양한 혈액응고 모니터링 제품을 출시하고 있습니다.
예를 들어, 2024년 2월 로슈는 CE 마크를 인정하는 국가에서 경구용 Factor Xa 억제제인 아픽사반, 에독사반, 리바록사반에 대한 세 가지 새로운 혈액응고 검사 키트를 출시했습니다.
또한, 2023년 7월 24일 Baxter International Inc.는 미국에서 PERCLOT 흡수성 지혈 분말을 출시했습니다. PERCLOT은 혈액응고 기능이 정상인 환자의 경미한 출혈에 사용하도록 설계된, 즉시 사용 가능한 흡수성 지혈 분말입니다. 따라서 이러한 요인들이 해당 지역이 시장 점유율에서 주도적인 위치를 유지하는 데 기여할 것으로 예상됩니다.
COVID-19 영향 분석
COVID-19는 의료 산업에 어느 정도 영향을 미쳤습니다. 확산 방지를 위해 정부는 봉쇄 조치를 시행했습니다. 사람들은 COVID-19 팬데믹으로 인해 직업적 영향과 건강 악화를 경험할 수 있다는 두려움을 느끼고 있습니다. 코로나19 환자에게서 과응고증이 관찰됨에 따라, FDA는 코로나19 공중보건 비상사태로 인해 환자 수가 증가하는 병원 및 기타 의료 시설에서 환자의 응고 장애를 검사하고 관리하는 데 필요한 기기의 보급을 확대하는 것이 중요하고 유용하다는 점을 인식했습니다. 이는 전 세계 응고 모니터링 제품 시장의 성장을 촉진했습니다.
시장 세분화
제품별
• 기기
o 점탄성 응고 모니터
o 항응고 모니터
o 혈소판 기능 모니터링 장치
o 지혈 분석기
• 검사법
o 항-Xa 검사
o 헤파린 검사
o 다이머 검사
• 시약
o 트롬보플라스틴
o 트롬보스판 LS
o 트롬보스판 LS aPTT-EA
최종 사용자별
• 병원
• 클리닉 및 진단 센터
• 가정
• 외래 진료
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체는 다음과 같습니다. 지멘스 헬스니어스, 코아구센스, 헤모소닉스, 호리바 ABX, 유니버설 바이오센서, 마인드레이 바이오메디컬 일렉트로닉스, 바이오제닉스, 마쿠라 바이오테크놀로지, 스클라보 다이애그노스틱스 인터내셔널, 헬레나 래버러토리스(영국) 등이 주요 기업입니다.

보고서 구매 이유:

• 제품, 최종 사용자, 지역별 글로벌 혈액응고 모니터링 제품 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악할 수 있습니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴할 수 있습니다.

• 모든 세그먼트를 포함한 혈액응고 모니터링 제품 시장 수준의 다양한 데이터가 담긴 엑셀 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품 정보를 담은 엑셀 파일 형태의 제품 맵핑 자료를 제공합니다. 글로벌 혈액응고 모니터링 제품 시장 보고서는 약 53개의 표, 47개의 그림, 그리고 176페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global coagulation monitoring products market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
Coagulation tests assess blood’s ability to clot as well as the time it takes to clot. Testing can assist a doctor in determining the risk of excessive bleeding or the formation of clots (thrombosis) in blood vessels. Coagulation monitoring devices are medical devices that measure the period it takes for blood to clot. This information is essential to diagnosing and managing a variety of bleeding and clotting disorders.
They measure numerous elements of the blood clotting process, enabling healthcare practitioners to identify bleeding disorders, monitor the efficacy of blood-thinning drugs (anticoagulants), and guide blood clotting treatment options.
Market Dynamics: Drivers & Restraints
Increasing number of coagulation monitoring products
Increasing number of advanced coagulation Monitor products and devices is expected to drive the market growth during the forecast period. The increasing launches of new advanced products to meet the needs of hospitals and patient requirements.
For instance, in March 2024, Aussie biosensor company Universal Biosensors received the US FDA and CLIA Waiver approval for its Xprecia Prime Coagulation Analyzer as a Class II device. Xprecia Prime is a portable coagulation monitoring device that provides fast and accurate PT/INR testing specifically for patients on vitamin K antagonist oral anticoagulation therapies like Warfarin.
Additionally in November 2023, Universal Biosensors introduced Xprecia Prime Coagulation Analyser, the new and improved coagulation monitoring device. Xprecia Prime is small, portable, accurate, and easy to use.
Also in July 2023, ARKRAY USA, Inc. launched the Assure PT Care PT/INR Monitoring System, in a strategic partnership with CoaguSense, Inc. Thus, the increasing number of product launches into the market will drive the market growth during the forecast period.
High cost of testing devices
The major reason restricting the use of medical devices such as POC coagulation monitoring devices is the high cost of these devices compared to the laboratory tests for monitoring. Due to limited economic opportunities, low and middle-income countries (LIC/MICs) face significant challenges.
For more details on this report – Request for Sample
Segment Analysis
The global coagulation monitoring products market is segmented based on product, end-user and region.
Viscoelastic coagulation monitor segment is expected to dominate the market growth
A viscoelastic blood analysis provides a dynamic in vitro assessment of global coagulation, from the beginning of clot formation to fibrinolysis in whole blood. The study includes the interaction of all coagulation components, including platelets, red blood cells, fibrin, coagulation factors, and thrombin. The viscoelastic coagulation monitor (VCM) System is a revolutionary technology that leverages glass surface activation of untreated whole blood.
It is a compact, portable instrument that may do a viscoelastic examination of the coagulation-fibrinolysis process at the patient's bedside. The rapid clotting begins due to the large surface contact area between the extracted blood and the glass inside the cartridge. Thus, the efficiency of these instruments is expected to hold the segment during the forecast period.
Geographical Analysis
North America is expected to hold a significant position in the coagulation monitoring products market share
North America is expected to hold a dominant position in the market share owing to the presence of a large number of manufacturers, highly equipped hospitals and also the increasing demand for the products by the increasing prevalence of blood disorders in the region. Market key players are introducing a new variety of products for coagulation monitoring to expand the company’s portfolio which can boost the market growth.
For instance, in February 2024, Roche launched three new coagulation tests for the oral Factor Xa inhibitors apixaban, edoxaban and rivaroxaban in countries accepting the CE mark.
Additionally, on July 24, 2023, Baxter International Inc. launched the PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding. Thus, the above factors are expected to hold the region in the dominant position in the market share.
COVID-19 Impact Analysis
COVID-19 has affected the healthcare industry moderately. To stop its spread, government-imposed lockdown. People are fearful they may experience occupational effects and negative health from the COVID-19 pandemic. Because hypercoagulability has been observed in COVID-19 patients, the FDA recognized the importance and utility of increasing the availability of devices to test for and manage coagulopathies in patients in hospitals and other healthcare facilities experiencing an increase in patient load as a result of the COVID-19 public health emergency. This has boosted the global coagulation monitoring products market.
Market Segmentation
By Product
• Instrument
o Viscoelastic Coagulation Monitor
o Anticoagulation Monitors
o Platelet Functioning Monitoring Devices
o Haemostasis Analyzer
• Assays
o Anti-Xa assay
o Heparin Assay
o Dimer Assay
• Reagents
o Thromboplastin
o Thrombospan LS
o Thrombospan LS aPTT-EA
By End-User
• Hospitals
• Clinics and Diagnostic centers
• Home Setting
• Ambulatory Settings
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Siemens Healthineers, CoaguSense Inc., Hemosonics LLC, Horiba ABX S.A., Universal Biosensors Inc., Mindray Bio-medical Electronics Co., Ltd., BIOGENIX INC. PVT. LTD., Maccura Biotechnology Co., Sclavo Diagnostics International S.r.l and Helena Laboratories (UK) Limited among others.
Why Purchase the Report?
• To visualize the global coagulation monitoring products market segmentation based on product, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of coagulation monitoring products market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global coagulation monitoring products market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by End-User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing number of coagulation monitoring products
4.1.1.2. YY
4.1.2. Restraints
4.1.2.1. High cost of testing devices
4.1.2.2. YY
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Instruments*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Viscoelastic Coagulation Monitor
7.2.4. Anticoagulation Monitors
7.2.5. Platelet Functioning Monitoring Devices
7.2.6. Haemostasis Analyzer
7.3. Assays
7.3.1. Anti-Xa assay
7.3.2. Heparin Assay
7.3.3. Dimer Assay
7.4. Reagents
7.4.1. Thromboplastin
7.4.2. Thrombospan LS
7.4.3. Thrombospan LS aPTT-EA
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics and Diagnostic centers
8.4. Home Setting
8.5. Ambulatory Settings
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.3.1. U.S.
9.2.3.2. Canada
9.2.3.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.4.1. Germany
9.3.4.2. UK
9.3.4.3. France
9.3.4.4. Italy
9.3.4.5. Spain
9.3.4.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.4.1. Brazil
9.4.4.2. Argentina
9.4.4.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.4.1. China
9.5.4.2. India
9.5.4.3. Japan
9.5.4.4. South Korea
9.5.4.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
9.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Siemens Healthineers *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. CoaguSense Inc.
11.3. Hemosonics LLC
11.4. Horiba ABX S.A.
11.5. Universal Biosensors Inc.
11.6. Mindray Bio-medical Electronics Co., Ltd.
11.7. BIOGENIX INC. PVT. LTD.
11.8. Maccura Biotechnology Co.
11.9. Sclavo Diagnostics International S.r.l
11.10. Helena Laboratories (UK) Limited
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Siemens Healthineers, 4.	Key Developments, CoaguSense Inc., Hemosonics  LLC, Horiba ABX S.A., Universal Biosensors Inc., Mindray Bio-medical Electronics Co., Ltd., BIOGENIX INC. PVT. LTD., Maccura Biotechnology Co., Sclavo Diagnostics International S.r.l, Helena Laboratories (UK) Limited

표 목록 (Tables)

List of Tables

Table 1 Global Coagulation Monitoring Products Market Value, By Product Type, 2024, 2029 & 2033 (US$ Million)

Table 2 Global Coagulation Monitoring Products Market Value, By End-User, 2024, 2029 & 2033 (US$ Million)

Table 3 Global Coagulation Monitoring Products Market Value, By Region, 2024, 2029 & 2033 (US$ Million)

Table 4 Global Coagulation Monitoring Products Market Value, By Product Type, 2024, 2029 & 2033 (US$ Million)

Table 5 Global Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 6 Global Coagulation Monitoring Products Market Value, By End-User, 2024, 2029 & 2033 (US$ Million)

Table 7 Global Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 8 Global Coagulation Monitoring Products Market Value, By Region, 2024, 2029 & 2033 (US$ Million)

Table 9 Global Coagulation Monitoring Products Market Value, By Region, 2018-2033 (US$ Million)

Table 10 North America Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 11 North America Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 12 North America Coagulation Monitoring Products Market Value, By Country, 2018-2033 (US$ Million)

Table 13 South America Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 14 South America Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 15 South America Coagulation Monitoring Products Market Value, By Country, 2018-2033 (US$ Million)

Table 16 Europe Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 17 Europe Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 18 Europe Coagulation Monitoring Products Market Value, By Country, 2018-2033 (US$ Million)

Table 19 Asia-Pacific Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 20 Asia-Pacific Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 21 Asia-Pacific Coagulation Monitoring Products Market Value, By Country, 2018-2033 (US$ Million)

Table 22 Middle East and Africa Coagulation Monitoring Products Market Value, By Product Type, 2018-2033 (US$ Million)

Table 23 Middle East and Africa Coagulation Monitoring Products Market Value, By End-User, 2018-2033 (US$ Million)

Table 24 Middle East and Africa Coagulation Monitoring Products Market Value, By Country, 2018-2033 (US$ Million)

Table 25 Siemens Healthcare AG: Overview

Table 26 Siemens Healthcare AG: Product Portfolio

Table 27 Siemens Healthcare AG: Key Developments

Table 28 Abbott Laboratories: Overview

Table 29 Abbott Laboratories: Product Portfolio

Table 30 Abbott Laboratories: Key Developments

Table 31 Beckman Coulter, Inc.: Overview

Table 32 Beckman Coulter, Inc.: Product Portfolio

Table 33 Beckman Coulter, Inc.: Key Developments

Table 34 Sysmex Corporation: Overview

Table 35 Sysmex Corporation: Product Portfolio

Table 36 Sysmex Corporation: Key Developments

Table 37 Thermo Fisher Scientific Inc.: Overview

Table 38 Thermo Fisher Scientific Inc.: Product Portfolio

Table 39 Thermo Fisher Scientific Inc.: Key Developments

Table 40 HemoSonics, LLC.: Overview

Table 41 HemoSonics, LLC.: Product Portfolio

Table 42 HemoSonics, LLC.: Key Developments

Table 43 Helena Laboratories Corporation.: Overview

Table 44 Helena Laboratories Corporation.: Product Portfolio

Table 45 Helena Laboratories Corporation.: Key Developments

Table 46 F. Hoffmann-La Roche Ltd.: Overview

Table 47 F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 48 F. Hoffmann-La Roche Ltd.: Key Developments

Table 49 Horiba Group: Overview

Table 50 Horiba Group: Product Portfolio

Table 51 Horiba Group: Key Developments

Table 52 Maccura Biotechnology Co., Ltd.: Overview

Table 53 Maccura Biotechnology Co., Ltd.: Product Portfolio

Table 54 Maccura Biotechnology Co., Ltd.: Key Developments

Table 55 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Overview

Table 56 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Product Portfolio

Table 57 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Key Developments

Table 58 Sclavo Diagnostics International SpA: Overview

Table 59 Sclavo Diagnostics International SpA: Product Portfolio

Table 60 Sclavo Diagnostics International SpA: Key Developments

Table 61 BIOGENIX INC. PVT. LTD.: Overview

Table 62 BIOGENIX INC. PVT. LTD.: Product Portfolio

Table 63 BIOGENIX INC. PVT. LTD.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 2 Global Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 4 Global Coagulation Monitoring Products Market Share, By Region, 2024 & 2033 (%)

Figure 5 Global Coagulation Monitoring Products Market Y-o-Y Growth, By Product Type, 2024-2033 (%)

Figure 6 Reagents Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 7 Assays Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 8 Instruments Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 9 Global Coagulation Monitoring Products Market Y-o-Y Growth, By End-User, 2024-2033 (%)

Figure 10 Hospitals End-User in Global Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 11 Clinics and Diagnostic Centers End-User in Global Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 12 Home Settings End-User in Global Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 13 Ambulatory Settings End-User in Global Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 14 Global Coagulation Monitoring Products Market Y-o-Y Growth, By Region, 2024-2033 (%)

Figure 15 North America Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 16 North America Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 17 North America Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 18 North America Coagulation Monitoring Products Market Share, By Country, 2024 & 2033 (%)

Figure 19 South America Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 20 South America Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 21 South America Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 22 South America Coagulation Monitoring Products Market Share, By Country, 2024 & 2033 (%)

Figure 23 Europe Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 24 Europe Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 25 Europe Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 26 Europe Coagulation Monitoring Products Market Share, By Country, 2024 & 2033 (%)

Figure 27 Asia-Pacific Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 28 Asia-Pacific Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 29 Asia-Pacific Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 30 Asia-Pacific Coagulation Monitoring Products Market Share, By Country, 2024 & 2033 (%)

Figure 31 Middle East and Africa Coagulation Monitoring Products Market Value, 2018-2033 (US$ Million)

Figure 32 Middle East and Africa Coagulation Monitoring Products Market Share, By Product Type, 2024 & 2033 (%)

Figure 33 Middle East and Africa Coagulation Monitoring Products Market Share, By End-User, 2024 & 2033 (%)

Figure 34 Siemens Healthcare AG: Financials

Figure 35 Abbott Laboratories: Financials

Figure 36 Beckman Coulter, Inc.: Financials

Figure 37 Sysmex Corporation: Financials

Figure 38 Thermo Fisher Scientific Inc.: Financials

Figure 39 HemoSonics, LLC.: Financials

Figure 40 Helena Laboratories Corporation.: Financials

Figure 41 F. Hoffmann-La Roche Ltd.: Financials

Figure 42 Horiba Group: Financials

Figure 43 Maccura Biotechnology Co., Ltd.: Financials

Figure 44 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Financials

Figure 45 Sclavo Diagnostics International SpA: Financials

Figure 46 BIOGENIX INC. PVT. LTD.: Financials

글로벌 혈액응고 모니터링 제품 시장 – 2024-2031년

Global Coagulation Monitoring Products Market - 2024-2031